Screener
CG Oncology CGON Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's accounts payable?
- CG Oncology (CGON) reported accounts payable of $12.73M in Q2 2026.
- How has CG Oncology's accounts payable changed year-over-year?
- CG Oncology's accounts payable increased by 78.6% year-over-year, from $7.13M to $12.73M.
- What is the long-term trend for CG Oncology's accounts payable?
- Over 2 years (2023 to 2025), CG Oncology's accounts payable has grown at a 172.6% compound annual growth rate (CAGR), from $3.87M to $28.76M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about CG Oncology's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude